Atlas Trials

A Phase II Study Evaluating Intranasal GSK256066 and Fluticasone Propionate in Subjects With Seasonal Allergic Rhinitis (SAR)

Clinical trial NCT00612820 · COMPLETED

Trial details

NCT number
NCT00612820
Sponsor
GlaxoSmithKline
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Rhinitis, Allergic, Seasonal
Start date
2008-01-01
Primary completion
2008-05-01
Enrollment
55

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.